CareDx (NASDAQ: CDNA) reported Q1 EPS of ($0.13), $0.08 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $79.4 million versus the consensus estimate of $78.92 million.

GUIDANCE:

CareDx sees FY2022 revenue of $330-350 million, versus the consensus of $342.2 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.